@article{b9e6115997524d4c9fe58583ede4a18c,
title = "Regional Differences in Secondary Prevention Therapy-Geography Should Not Be Destiny",
author = "Navar, {Ann Marie} and Fonarow, {Gregg C.}",
note = "Funding Information: grants and personal fees from Amarin, Amgen, Regeneron, and Sanofi; personal fees from Novo Nordisk and AstraZeneca; and grants from Janssen, outside the submitted work. Dr Fonarow reports research funding from the National Institutes of Health and personal fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis, outside the submitted work. Funding Information: funding from the National Institutes of Health;",
year = "2019",
month = sep,
doi = "10.1001/jamacardio.2019.2548",
language = "English (US)",
volume = "4",
pages = "873",
journal = "JAMA Cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "9",
}